Akcea Therapeutics, Inc.

Akcea Therapeutics, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Akcea Therapeutics, Inc. is a mediocre stock to choose.
Log in to see more information.
Akcea Therapeutics, Inc. engages in the development and marketing of drugs globally to treat patient...

News